1
Spiridon Spireas, Ishari Piya, Rakesh Grover, Sunil Sagi, Ram K Kallur: Highly stable compositions of orally active nucleotide analogues or orally active nucleotide analogue prodrugs. Sigmapharm Laboratories, Leydig Voit & Mayer, April 18, 2017: US09622967

Disclosed are highly stable compositions having outstanding storage stability and/or demonstrating exceptional resistance to aqueous solution degradation, the composition including an orally active nucleotide analog or an orally active nucleotide analog prodrug, which is orally bioavailable, such as ...


2
Spiridon Spireas, Ishari Piya, Rakesh Grover, Sunil Sagi, Ram K Kallur: Highly stable compositions of orally active nucleotide analogues or orally active nucleotide analogue prodrugs. Sigmapharm Laboratories, August 2, 2012: US20120196834-A1

Disclosed are highly stable compositions having outstanding storage stability and/or demonstrating exceptional resistance to aqueous solution degradation, the composition including an orally active nucleotide analogue or an orally active nucleotide analogue prodrug, which is orally bioavailable, suc ...


3
SPIREAS Spiridon, PIYA Ishari, GROVER Rakesh, SAGI Sunil, KALLUR Ram K: COMPOSITIONS TRÈS STABLES DANALOGUES NUCLÉOTIDIQUES ACTIFS PAR VOIE ORALE OU DE PROMÉDICAMENTS SOUS FORME DANALOGUES NUCLÉOTIDIQUES ACTIFS PAR VOIE ORALE, HIGHLY STABLE COMPOSITIONS OF ORALLY ACTIVE NUCLEOTIDE ANALOGUES OR ORALLY ACTIVE NUCLEOTIDE ANALOGUE PRODRUGS. SIGMAPHARM LABORATORIES, SPIREAS Spiridon, PIYA Ishari, GROVER Rakesh, SAGI Sunil, KALLUR Ram K, PILLAI Xavier, June 14, 2012: WO/2012/079035

Disclosed are highly stable compositions having outstanding storage stability and/or demonstrating exceptional resistance to aqueous degradation, the composition including an orally active nucleotide analogue or an orally active nucleotide analogue prodrug, which is orally bioavailable, such as adef ...


4

5
[ZH] 口服活性核苷酸类似物或口服活性核苷酸类似物前药的高度稳定组合物, [EN] Highly stable compositions of orally active nucleotide analogues or orally active nucleotide analogue prodrugs. June 3, 2015: CN137674416

[EN] Disclosed are highly stable compositions having outstanding storage stability and/or demonstrating exceptional resistance to aqueous solution degradation, the composition including an orally active nucleotide analogue or an orally active nucleotide analogue prodrug, which is orally bioavailable ...